ArticleBioresources and bioprocessing2025
Advancing the synthesis of trimethylene carbonate: a high-yield green synthesis route.
Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trimethylene carbonate (TMC) is an innovative modifier for polylactic acid and a promising biodegradable polymer monomer with broad application potential. However, industrial production of TMC faces challenges such as high catalyst costs, safety issues, and environmental impacts. Enzymatic catalysis offers a potential alternative, but its low product yields have hindered progress. In this study, we introduce a novel synthesis route for TMC using bio-based 1,3-propanediol (1,3-PDO) and dimethyl carbonate (DMC) as substrates. This process involves lipase-catalyzed formation of the intermediate 3-hydroxypropyl methyl carbonate (P1), which is then cyclized to produce TMC. Notably, the by-product, C,C'-1,3-propanediyl C,C'-dimethyl ester (P2), reacts with 1,3-PDO to regenerate P1, further enhancing the overall TMC yield. The mechanism exploration reveals that 1,3-PDO acts as both a reactant and an acid catalyst, initiating a nucleophilic substitution reaction on P2 to produce P1. Under optimized conditions, we achieved a total TMC yield of 88%, the highest reported to date.This study provides a novel green synthesis route for TMC that holds great promise for industrial application, given its safer conditions and competitive yields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.